Medbox Inc. (OTC:MDBX) features patented systems that dispense medication based on biometric identification (fingerprint sample). Our newly designed systems allow pharmacies, assisted living facilities, prisons, hospitals, doctors’ offices, and alternative medicine clinics to help manage employee possession of sensitive drugs. In a retail environment typical in most alternative medicine clinics, the system also allows these clinics to document that the user is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. Each transaction is tracked internally for accounting and compliance purposes. Patient information is all kept securely onsite and is not online as the software is completely self-supportive and does not require an internet connection. In alternative medicine clinics, the machine sits behind the counter, is not accessible by the consumer, and is at the control of the clinic employee as an inventory management and compliance tool.
Invest In MJ Charts:
Alternatively, the MDS machines are used in assisted living facilities, prisons, and urgent care centers directly by nurses and authorized staff. Once at the machine, authorized personnel gain access by simply swiping their registration card, verifying their fingerprint, and choosing the medicine they need. Medicines are dispensed in a variety of doses in a temperature controlled environment as the MDS machine has ample room for various sizes of medicine vials as well as slight refrigeration when needed. All medicines are dispensed in standard pharmaceutical vials or customized packaging, as needed, through the MDS machine.
Medbox, through its subsidiaries, offers turn-key consulting services to the pharmaceutical industry. The Company also provides consulting services to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning the availability of alternative medicines as well as existing jurisdictions, nationwide.
Medbox also engages in the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol R&D, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and also alternative medicine dispensary management services.
We have been awarded United States & Canadian Patents concerning the software and hardware related to our medicine dispensing machine. Our company’s founder has appeared in interviews with CNN, ABCNews, Reuters, Associated Press, NPR, and has been featured in articles appearing in Newsweek, Los Angeles Times, and the Wall Street Journal, as well as over 30 other news agencies around the world concerning our cutting-edge products and services.
Medbox Founder Comments on Signing $15M Equity Deal
Founder Further Comments on Signing a Deal Transferring the Majority of His Shares to an Industry Player and Directing $5M of the Proceeds to Medbox Through Equity Purchase
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) — P. Vincent Mehdizadeh, founder and current majority shareholder of Medbox, Inc. (MDBX) commented on executing a deal with Lizada Capital LLC, an investor in the field of legal cannabis products, that would result in the transfer of the majority of Mr. Mehdizadeh’s shares of MDBX to that firm.
Under the agreement, which has six separate closings over 18 months, Lizada would purchase 22,160,000 shares, representing 2,000,000 preferred shares and 12,160,000 common shares of Medbox for upwards of $15 million. A total of $5 million of the funds have been designated for purchase of 2.5 million restricted shares of Medbox common stock, directly from Medbox, in the name of Mr. Mehdizadeh’s holding company, PVM International, Inc.
“Prior to announcing the deal yesterday, the Medbox board of directors had approved the Lizada Capital LLC managing member to join the board of directors as my board appointment and also approved of that party making a substantial direct investment into the company for the purchase of restricted common stock,” stated Vincent Mehdizadeh, founder and current majority shareholder of Medbox. “I also discussed the possibility of having Lizada step into my shoes as the majority shareholder of the company and shared the potential deal points with the Medbox board of directors and their attorneys weeks before a final agreement was reached with Lizada. While Medbox is not a direct party to this transaction, they have been in the loop and have been supportive in vetting Lizada’s investment and its managing member’s appointment to the Medbox board of directors. The next steps for the investment into Medbox will be signing subscription agreements with the company that will tie into each of the first 5 closings identified within the Lizada transaction. From what my attorneys and I can gather, the signing of subscription agreements with Medbox is simply a formality. I am happy to be bringing value to Medbox and its shareholders in this manner.”
To view a copy of the executed agreement between the parties, please click on the link below:
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=10537768
About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox’s main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the two main patents behind the company’s technology, helping to assemble the talented board/management team at Medbox, and also developing the concept behind the business models driving revenue for the company. Mr. Mehdizadeh was responsible for funding and the creation of the Marijuana Policy Project “Consume Responsibly” campaign, as well as the Americans For Safe Access “Medicate Responsibly” campaign. Mehdizadeh has donated over $2 million dollars to Americans for Safe Access (ASA), Marijuana Policy Project (MPP), Drug Policy Alliance (DPA), Law Enforcement Against Prohibition (LEAP), and St. Jude Children’s Research Hospital.
About Lizada Capital LLC:
Lizada is a privately held entity formed in 2004 for the principal purpose of investing in emerging market opportunities. In 2013, following a two-year period of industry evaluation, the company started primarily focusing on the cannabis industry, Since then, Lizada has invested in public companies including GW Pharmaceuticals, AmeriCann and CannLabs and private companies, CDX, MJIC, Panther Capital, New Frontier, Noble Blends, Medicine Man Technologies, Las Vegas CannaPlex and Quigley’s.